Enhancement of μ-opioid receptor desensitization by nitric oxide in rat locus coeruleus neurons: Involvement of reactive oxygen species

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 2, 2012, Pages 552-560

  Llorente, J ^a,c   Santamarta, M T ^a   Henderson, G ^b   Pineda, Joseba ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ALPHA 2 ADRENERGIC RECEPTOR; DIETHYLDITHIOCARBAMIC ACID; HYDROGEN PEROXIDE; METENKEPHALIN; MU OPIATE RECEPTOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONCENTRATION (PARAMETERS); DESENSITIZATION; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; LOCUS CERULEUS; MALE; NERVE CELL; NONHUMAN; PATCH CLAMP; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; WHOLE CELL;

ANIMALS; ANTIOXIDANTS; CHROMANS; DITIOCARB; ENKEPHALIN, METHIONINE; HYDRAZINES; HYDROGEN PEROXIDE; LOCUS COERULEUS; MALE; MELATONIN; NEURONS; NITRIC OXIDE; NITROPRUSSIDE; NOREPINEPHRINE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID, MU;

EID: 84864150038     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.194225     Document Type: Article

References (43)

1. Aghajanian GK and Wang YY (1987) Common α2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 26:793-799. (Pubitemid 17124655)
2. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, and Williams JT (2002) μ-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22:5769-5776. (Pubitemid 35386500)
3. 2-mediated inhibition of synaptic transmission in rat hippocampal slices. Brain Res 882:86-94.
4. Bailey CP, Kelly E, and Henderson G (2004) Protein kinase C activation enhances morphine-induced rapid desensitization of μ-opioid receptors in mature rat locus ceruleus neurons. Mol Pharmacol 66:1592-1598. (Pubitemid 39564786)
5. Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, and Henderson G (2009) Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci 29:307-318.
6. Balogh GT, Vukics K, Könczöl A, Kis-Varga A, Gere A, and Fischer J (2005) Nitrone derivatives of trolox as neuroprotective agents. Bioorg Med Chem Lett 15:3012-3015. (Pubitemid 40755187)
7. Bannister JP, Young BA, Main MJ, Sivaprasadarao A, and Wray D (1999) The effects of oxidizing and cysteine-reactive reagents on the inward rectifier potassium channels Kir2.3 and Kir1.1. Pflugers Arch 438:868-878. (Pubitemid 29501000)
8. Cuéllar B, Fernández AP, Lizasoain I, Moro MA, Lorenzo P, Bentura ML, Rodrigo J, and Leza JC (2000) Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl) 148:66-73. (Pubitemid 30062474)
9. Davis KL, Martin E, Turko IV, and Murad F (2001) Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236. (Pubitemid 32385888)
10. Desvignes C, Robert F, Vachette C, Chouvet G, Cespuglio R, Renaud B, and Lambás-Señas L (1997) Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors. Neuroreport 8:1321-1325. (Pubitemid 27242529)
11. Harris GC and Williams JT (1991) Transient homologous μ-opioid receptor desensitization in rat locus coeruleus neurons. J Neurosci 11:2574-2581.
12. Heinzen EL, Booth RG, and Pollack GM (2005) Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the μ-opioid receptor. Biochem Pharmacol 69:679-688.
13. Highfield DA and Grant S (1998) Ng-nitro-L-arginine, an NOS inhibitor, reduces tolerance to morphine in the rat locus coeruleus. Synapse 29:233-239. (Pubitemid 28267932)
14. Keefer LK, Nims RW, Davies KM, and Wink DA (1996) "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268:281-293. (Pubitemid 26286370)
15. Khalil A, Fortun A, Hébert S, Jay-Gerin JP, El Abbouyi A, Wallach J, and Fülöp T Jr (1998) Novel 21-aminosteroid U-74389G inhibits low-density lipoprotein peroxidation induced by. OH and O2-. free radicals. Life Sci 63:769-779. (Pubitemid 28383726)
16. Knapp LT and Klann E (2002) Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C. J Neurosci 22:674-683. (Pubitemid 34141748)
17. Koch T, Seifert A, Wu DF, Rankovic M, Kraus J, Börner C, Brandenburg LO, Schröder H, and Höllt V (2009) μ-Opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2. J Neurochem 110:1288-1296.
18. Liu J, Shigenaga MK, Yan LJ, Mori A, and Ames BN (1996) Antioxidant activity of diethyldithiocarbamate. Free Radic Res 24:461-472. (Pubitemid 26188964)
19. Liu JG and Anand KJ (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38:1-19.
20. McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, Dewey WL, Bailey CP, Rosethorne EM, Charlton SJ, et al. (2010) μ-Opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol 78:756-766.
21. Melief EJ, Miyatake M, Bruchas MR, and Chavkin C (2010) Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A 107:11608-11613.
22. 3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices. Neuroscience 120:771-781.
23. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63. (Pubitemid 27446271)
24. Nishida M, Schey KL, Takagahara S, Kontani K, Katada T, Urano Y, Nagano T, Nagao T, and Kurose H (2002) Activation mechanism of Gi and Go by reactive oxygen species. J Biol Chem 277:9036-9042. (Pubitemid 34952977)
25. Noda Y, Mori A, Liburdy R, and Packer L (1999) Melatonin and its precursors scavenge nitric oxide. J Pineal Res 27:159-163. (Pubitemid 29487960)
26. Osborne PB and Williams JT (1995) Characterization of acute homologous desensitization of μ-opioid receptor-induced currents in locus coeruleus neurones. Br J Pharmacol 115:925-932.
27. Pellmar TC, Gilman SC, Keyser DO, Lee KH, Lepinski DL, Livengood D, and Myers LS Jr (1994) Reactive oxygen species on neural transmission. Ann NY Acad Sci 738:121-129.
28. Pineda J, Kogan JH, and Aghajanian GK (1996) Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J Neurosci 16:1389-1399. (Pubitemid 26145919)
29. Pineda J, Torrecilla M, Martín-Ruiz R, and Ugedo L (1998) Attenuation of withdrawal- induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats. Neuropharmacology 37:759-767. (Pubitemid 28313901)
30. Poderoso JJ, Carreras MC, Lisdero C, Riobó N, Schöpfer F, and Boveris A (1996) Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 328:85-92. (Pubitemid 26108173)
31. Raghavendra V and Kulkarni SK (2000) Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol 409:279-289.
32. Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Wang JB, and Garzón J (2008) NMDAR-nNOS generated zinc recruits PKCγ to the HINT1-RGS17 complex bound to the C terminus of μ-opioid receptors. Cell Signal 20: 1855-1864.
33. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D (2003) Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl- amide intermediate. Nature 423:769-773. (Pubitemid 36735701)
34. Santamarta MT, Ulibarri I, and Pineda J (2005) Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats. Synapse 57:38-46. (Pubitemid 40756333)
35. Smith JN and Dasgupta TP (2001) Mechanisms of nitric oxide release from nitrovasodilators in aqueous solution: reaction of the nitroprusside ion ([Fe(CN)5NO]2) with L-ascorbic acid. J Inorg Biochem 87:165-173. (Pubitemid 33109096)
36. Taylor DA and Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11-18. (Pubitemid 32242558)
37. Torrecilla M, Pineda J, and Ugedo L (2001) NO synthase inhibitors reduce opioid desensitization in rat locus coeruleus neurons in vitro. Neuroreport 12:1601-1604. (Pubitemid 32521471)
38. Torrecilla M, Ruiz-Ortega JA, Ugedo L, and Pineda J (2007) Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. Naunyn Schmiedebergs Arch Pharmacol 375:337-347. (Pubitemid 46945333)
39. Ugedo L, Garro MA, Pineda J, Giralt MT, Miralles A, Olmos G, García-Sevilla JA, Menargues A, and Obach R (1993) Acute and chronic effects of reserpine on biochemical and functional parameters of central and peripheral α2-adrenoceptors. Eur J Pharmacol 239:149-157. (Pubitemid 23240153)
40. Tayfun Uzbay I and Oglesby MW (2001) Nitric oxide and substance dependence. Neurosci Biobehav Rev 25:43-52. (Pubitemid 32101388)
41. Vlkolinský R, Stolc S, and Ross A (1999) Effect of stobadine, U-74389G, trolox and melatonin on resistance of rat hippocampal slices to oxidative stress. Life Sci 65:1969-1971. (Pubitemid 29506938)
42. Williams JT and North RA (1984) Opiate-receptor interactions on single locus coeruleus neurones. Mol Pharmacol 26:489-497. (Pubitemid 15190712)
43. Xu B, Wang Z, Li G, Li B, Lin H, Zheng R, and Zheng Q (2006) Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome. Basic Clin Pharmacol Toxicol 99:153-161. (Pubitemid 44213944)